We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+1.9%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$165M
AUM Growth
+$4.34M
Cap. Flow
+$1.88M
Cap. Flow %
1.14%
Top 10 Hldgs %
23.21%
Holding
95
New
1
Increased
36
Reduced
23
Closed

Sector Composition

Rank Sector Weight
1 Industrials 16.35%
2 Technology 12.09%
3 Healthcare 11.32%
4 Financials 10.96%
5 Consumer Staples 10.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPG icon
76
PPG Industries
PPG
$26.4B
$385K 0.23%
3,700
LLY icon
77
Eli Lilly
LLY
$1.07T
$379K 0.23%
4,815
XLE icon
78
State Street Energy Select Sector SPDR ETF
XLE
$38.9B
$361K 0.22%
10,600
-1,680
-14% -$55.4K
YUM icon
79
Yum! Brands
YUM
$40.7B
$358K 0.22%
6,009
GAS
80
DELISTED
AGL Resources Inc
GAS
$305K 0.18%
4,634
EMR icon
81
Emerson Electric
EMR
$83.6B
$301K 0.18%
5,780
WM icon
82
Waste Management
WM
$95.6B
$297K 0.18%
4,490
-3,755
-46% -$227K
ORCL icon
83
Oracle
ORCL
$345B
$277K 0.17%
6,770
OXY icon
84
Occidental Petroleum
OXY
$54.6B
$274K 0.17%
3,630
ITW icon
85
Illinois Tool Works
ITW
$81.9B
$268K 0.16%
2,580
EFA icon
86
iShares MSCI EAFE ETF
EFA
$76.8B
$254K 0.15%
4,566
-8,050
-64% -$463K
SO icon
87
Southern Company
SO
$109B
$254K 0.15%
4,750
CAT icon
88
Caterpillar
CAT
$402B
$252K 0.15%
3,332
DHR icon
89
Danaher
DHR
$138B
$244K 0.15%
3,596
GPC icon
90
Genuine Parts
GPC
$17.6B
$241K 0.15%
2,390
EEM icon
91
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$237K 0.14%
6,918
-15,410
-69% -$517K
UNP icon
92
Union Pacific
UNP
$178B
$228K 0.14%
2,620
DD
93
DELISTED
Du Pont De Nemours E I
DD
$228K 0.14%
3,530
VFC icon
94
VF Corp
VFC
$6.71B
$212K 0.13%
3,675
CLX icon
95
Clorox
CLX
$11.8B
$211K 0.13%
+1,530
New +$198K

Similar funds

Boston Research & Management's Q2 2016 Portfolio in Review

As of Q2 2016, Boston Research & Management held 95 positions worth $165M, up 2.7% from $161M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2016: portfolio turnover was 1.1%. Boston Research & Management opened 1 new position and made no exits, leaving the 95-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • Boston Research & Management's largest Q2 2016 buy was Clorox: 1,530 shares worth $211K.
  • Boston Research & Management added most to iShares Core MSCI Emerging Markets ETF in Q2 2016, an estimated $667K increase.
  • Boston Research & Management's biggest Q2 2016 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $517K.
  • Boston Research & Management's ten largest holdings make up 23% of its $165M portfolio in Q2 2016.
  • Boston Research & Management opened 1 new position and closed 0 in Q2 2016.
  • Boston Research & Management's portfolio value rose 2.7% quarter-over-quarter to $165M.

Based on Boston Research & Management's 13F filing for Q2 2016, filed 10 Aug 2016.